ImmuCell Corporation is an animal health biologics company founded in 1982 that develops, manufactures, and commercializes products to improve the health and survivability of neonatal dairy and beef calves. The company’s primary product line, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies against the principal causes of neonatal calf scours, including Escherichia coli, bovine coronavirus, and bovine rotavirus. Key products include Dual-Force and Tri-Shield, which are USDA-licensed single-dose boluses and gels, as well as First Defense Technology bulk powder feed ingredients. ImmuCell also offers a California Mastitis Test for on-farm diagnostics. The company serves commercial dairy operations, specialized calf ranches, and beef producers in the United States and Canada, with products distributed through a network of international, national, and regional animal health distributors. Its manufacturing processes involve proprietary vaccine development, dairy herd hyperimmunization management, and antibody purification.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Agricultural Inputs Homepage immucell.com
Sector Basic Materials IR page immucell.com/investors
Tags
animal health, bovine colostrum, calf scours prevention, veterinary biologics, dairy cattle, beef cattle, neonatal health, hyperimmunization, feed supplements, mastitis diagnostics, First Defense, Dual-Force, Tri-Shield, First Defense Technology, California Mastitis Test, Immediate Immunity
Press page immucell.com/investors/news

Metrics

Valuation  
Market cap $ 89.086M
Market cap (USD) $ 89.086M
P/E 51.58
PEG —
P/BV 2.72
P/S 2.68
P/OCF 11.38
P/FCF 16.49
Dividend yield —
Turnover / mcap —
Returns  
ROE -3.8%
ROI -2.9%
ROIC 3.4%
Profit margin -3.8%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 24.1%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 22
Quality score 0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 27.644M 26.493M 17.472M 18.568M 19.243M 15.342M 13.723M 10.986M 10.431M 9.544M 10.229M 7.597M 6.007M 5.39M 5.111M 4.386M 4.509M 4.634M 6.069M 4.983M 3.696M 3.357M 6.185M — —
Net profit -1.04M -2.157M -5.775M -2.494M -78.292K -1.022M -1.296M -2.322M -168.147K 508.448K 1.213M -167.159K 117.395K 89.512K -409.51K -384.684K -216.493K -468.557K 662.138K 707.782K 143.519K 411.216K 886.237K 420.435K —
Free cash flow 1.225M -107.822K -6.567M -5.519M -1.654M -2.757M -1.158M -2.403M -16.584M -3.91M 181.047K -1.233M 500.963K 68.995K -281.05K -925.16K -569.213K -357.487K -1.178M 579.648K 1.02M 1.1M 1.648M 10.253K —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 6.15 5.15 5.09 6.1 8 5.96 5.15 7.04 8.78 5.95 7.4 4.87 4.26 5.1 3.2 2 3.7 1.87 3.27 — — — — — —
Price performance 12m 0.19 0.01 -0.17 -0.24 0.34 0.16 -0.27 -0.2 0.48 -0.2 0.52 0.14 -0.16 0.59 0.6 -0.46 0.98 -0.43 -0.52 — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 992,390 1.34M 932,298 1.64M 1.8M 2.69M 1.76M 2.19M 3.77M 3.42M
↳ YoY growth +31.6% +35.4% -30.6% +75.6% +9.8% +49.9% -34.7% +24.3% +72.6% -9.3%
↳ 5y CAGR +23.4% +18.5% +8.1% +10.2% +19.0% +22.1% +5.5% +18.6% +18.2% +13.7%
Borrowings, current (USD) — 9.09M 9.38M 8.52M — — 1.04M 10.4M 1.5M 1.61M
Borrowings, non-current (USD) — — — — — — 9.19M 10.5M 9.04M 7.49M
Lease liabilities (USD) — — — — 1.24M 1.14M 2.25M 4.72M 4.56M 4.1M
Cash and deposits (USD) 5.15M 3.8M 2.52M 6.29M 6.95M 10.2M 5.79M 978,741 3.76M 3.81M
Intangible assets (USD) 171,936 152,832 133,728 114,624 95,520 76,416 57,312 38,208 19,104 0.00
Right-of-use assets (USD) — — — — 1.22M 1.11M 2.19M 4.57M 4.56M 4.38M
Net debt (borrowings + leases - cash) (USD) — 5.29M 6.86M 2.23M — — 6.69M 24.7M 11.3M 9.39M
Cash flow detail
Operating cash flow (USD) -323,902 1.18M -373,404 233,511 1.32M 954,170 -1.54M -4.67M 357,903 2.48M
Purchases of property, plant and equipment (USD) -3.59M -17.8M -2.03M -1.39M -4.07M -2.61M -3.98M -1.89M -465,725 -1.25M
Change in receivables (cash effect) (USD) -274,287 -330,306 — — — — 935,629 -426,783 -1.59M 352,124
Change in inventories (cash effect) (USD) -1.14M 77,167 -281,939 -186,585 425,742 -997,460 -2.95M -1.77M 699,218 -2.15M
Change in payables (cash effect) (USD) -182,508 448,641 80,162 -88,711 299,881 245,760 341,614 156,995 362,606 -195,254
Interest paid (cash effect) (USD) -153,093 -186,542 -403,535 -420,956 -481,408 -308,682 -338,516 -444,954 -528,907 -443,019
Income taxes paid (cash effect) (USD) -123,584 -6,066 -4,222 -3,566 -4,581 -5,110 -4,923 -6,466 -7,293 -10,691
Share-based compensation (USD) 67,399 199,783 344,016 313,144 253,135 144,313 266,244 368,866 325,551 295,871
Operating cash flow before change in receivables (USD) -49,615 1.51M — — — — -2.48M -4.25M 1.94M 2.12M
Free cash flow (OCF - PPE - intangibles) (USD) -3.91M -16.6M -2.4M -1.16M -2.76M -1.65M -5.52M -6.57M -107,822 1.22M
Income detail
Research and development expense (USD) 1.24M 2.05M 3.52M 3.69M 4.35M 4.17M 4.49M 4.39M 3.9M 3.04M
↳ 5y CAGR -6.3% +17.4% +25.0% +11.1% +28.7% +27.4% +17.0% +4.6% +1.1% -6.9%
Total comprehensive income (USD) 534,802 -144,883 -2.29M -1.37M -978,222 -78,292 — — — —
Comprehensive income to owners (USD) 534,802 -144,883 -2.29M -1.37M -978,222 -78,292 — — — —
Reported Mar 30, 2017 Mar 29, 2018 Mar 22, 2019 Mar 27, 2020 Mar 30, 2021 Mar 30, 2022 Apr 1, 2024 Apr 1, 2024 Mar 28, 2025 Mar 30, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

For Immediate Release

PORTLAND, Maine – October 12, 2026 – ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity, today announced preliminary, unaudited sales results for the third quarter of 2026.

Management’s Discussion:

“Today we are reporting net income of $953,000 for the third quarter of 2026, a $1.1 million increase compared to the third quarter of 2025,” commented Timothy C. Fiori, Chief Financial Officer of ImmuCell. “Revenue grew 46.0% to $8.0 million in the third quarter of 2026 compared to the third quarter of 2025, a comparison aided in part by the absence of distributor restocking headwinds that had adversely affected the third quarter sales in 2025.

Revisit consent button

We value your privacy

We use cookies to enhance your browsing experience and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Reject All Accept All

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... Show more

NecessaryAlways Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

  • Cookie

    cookieyes-consent

  • Duration

    1 year

  • Description

    CookieYes sets this cookie to remember users' consent preferences so that their preferences are respected on subsequent visits to this site. It does not collect or store any personal information about the site visitors.

  • Cookie

    wpEmojiSettingsSupports

  • Duration

    session

  • Description

    WordPress sets this cookie when a user interacts with emojis on a WordPress site. It helps determine if the user's browser can display emojis properly.

  • Cookie

    __cf_bm

  • Duration

    1 hour

  • Description

    This cookie, set by Cloudflare, is used to support Cloudflare Bot Management.

Functional

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

  • Cookie

    ytidb::LAST_RESULT_ENTRY_KEY

  • Duration

    Never Expires

  • Description

    The cookie ytidb::LAST_RESULT_ENTRY_KEY is used by YouTube to store the last search result entry that was clicked by the user. This information is used to improve the user experience by providing more relevant search results in the future.

  • Cookie

    __Secure-BUCKET

  • Duration

    6 months

  • Description

    Description is currently not available.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

  • Cookie

    _ga

  • Duration

    1 year 1 month 4 days

  • Description

    Google Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors.

  • Cookie

    _ga_*

  • Duration

    1 year 1 month 4 days

  • Description

    Google Analytics sets this cookie to store and count page views.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

  • Cookie

    YSC

  • Duration

    session

  • Description

    Youtube sets this cookie to track the views of embedded videos on Youtube pages.

  • Cookie

    VISITOR_INFO1_LIVE

  • Duration

    6 months

  • Description

    YouTube sets this cookie to measure bandwidth, determining whether the user gets the new or old player interface.

  • Cookie

    VISITOR_PRIVACY_METADATA

  • Duration

    6 months

  • Description

    YouTube sets this cookie to store the user's cookie consent state for the current domain.

  • Cookie

    __Secure-ROLLOUT_TOKEN

  • Duration

    6 months

  • Description

    YouTube sets this cookie to manage feature rollout and experimentation. It helps Google control which new features or interface changes are shown to users as part of testing and staged rollouts, ensuring consistent experience for a given user during an experiment.

  • Cookie

    __Secure-YNID

  • Duration

    6 months

  • Description

    YouTube cookie used to protect user security and prevent fraud, especially during the login process.

  • Cookie

    __Secure-YEC

  • Duration

    past

  • Description

    Description is currently not available.

Uncategorised

Other uncategorised cookies are those that are being analysed and have not been classified into a category as yet.

No cookies to display.

Reject All Save My Preferences Accept All

Powered by Cookieyes logo

Skip to content

Immucell - First Defense

Find a Retailer

Immucell - First Defense

Toggle Menu

BLOG

Practical ideas and answers to calf health and calf scours prevention.

Calf eating near hay on farm

Mind the gap: the bioactives colostrum replacers leave out

By Rebekah Mathews, M.S.

Providing enough maternal colostrum for every calf isn’t always possible. In those cases, colostrum replacers are necessary to supply crucial vitamins, fat, protein, and more. Yet colostrum replacers vary in quality, and while they meet the “minimum” nutrient needs of a newborn calf, they can lack essential components the calf is expecting.

The current minimum recommended IgG intake for a newborn calf is 200 g (DCHA Gold Standards, 2026). Many colostrum replacers also supply high levels of fat and protein through various ingredients, which is certainly important for a calf that needs a few nutrient-dense meals after birth. To keep replacers affordable, manufacturers use ingredients that meet these macronutrient requirements. Here is what those products may lack.

Bioactive Components

Bioactive: having an effect on a living organism (Merriam-Webster)

  • Lactoferrin – binds iron, depriving pathogens of it
  • Growth factors – promote gut maturation
  • Enzymes – provide antiviral and antibacterial properties
  • Cytokines – modulate the immune response, such as recruiting white blood cells to infection sites
  • Hormones – support development of the gut, and possibly other systems
  • And MUCH more!

So What?

Sounds nice – but Rebekah, you already agreed there are situations outside our control where we need to rely on colostrum replacer!

Yup, I sure did. And please keep using it! First Defense products are rich in bovine bioactives and offer what the calf is asking for – and needs – by providing the crucial components calves have evolved to require. This is valuable for all calves: those fed colostrum from cows AND those receiving colostrum replacer. When every calf gets First Defense, with its bioactives AND specific pathogen protection, it receives what its new system requires. How would better preparing calves for life improve your operation?

References

A Comprehensive Review of Bovine Colostrum Components and Selected Aspects Regarding Their Impact on Neonatal Calf Physiology
https://pmc.ncbi.nlm.nih.gov/articles/PMC11010951

Recent Posts

First Defense products are developed and manufactured by ImmuCell Corporation, an entrepreneurial animal health company that develops, manufactures and markets scientifically proven products that maximize the genetic potential of dairy and beef calves through disease prevention and reduced dependence on antibiotics.

Where to purchase First Defense Get our research and insights

Facebook YouTube Instagram

ImmuCell Corporation

56 Evergreen Drive
Portland, ME 04103
Phone: 800.466.8235

© 2026 Immucell Corporation | All Rights Reserved | Privacy Policy | Terms of Use | Resource Login | FFL

Find a Retailer

Revisit consent button

We value your privacy

We use cookies to enhance your browsing experience and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Reject All Accept All

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... Show more

NecessaryAlways Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

  • Cookie

    cookieyes-consent

  • Duration

    1 year

  • Description

    CookieYes sets this cookie to remember users' consent preferences so that their preferences are respected on subsequent visits to this site. It does not collect or store any personal information about the site visitors.

  • Cookie

    wpEmojiSettingsSupports

  • Duration

    session

  • Description

    WordPress sets this cookie when a user interacts with emojis on a WordPress site. It helps determine if the user's browser can display emojis properly.

  • Cookie

    __cf_bm

  • Duration

    1 hour

  • Description

    This cookie, set by Cloudflare, is used to support Cloudflare Bot Management.

Functional

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

  • Cookie

    ytidb::LAST_RESULT_ENTRY_KEY

  • Duration

    Never Expires

  • Description

    The cookie ytidb::LAST_RESULT_ENTRY_KEY is used by YouTube to store the last search result entry that was clicked by the user. This information is used to improve the user experience by providing more relevant search results in the future.

  • Cookie

    __Secure-BUCKET

  • Duration

    6 months

  • Description

    Description is currently not available.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

  • Cookie

    _ga

  • Duration

    1 year 1 month 4 days

  • Description

    Google Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors.

  • Cookie

    _ga_*

  • Duration

    1 year 1 month 4 days

  • Description

    Google Analytics sets this cookie to store and count page views.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

  • Cookie

    YSC

  • Duration

    session

  • Description

    Youtube sets this cookie to track the views of embedded videos on Youtube pages.

  • Cookie

    VISITOR_INFO1_LIVE

  • Duration

    6 months

  • Description

    YouTube sets this cookie to measure bandwidth, determining whether the user gets the new or old player interface.

  • Cookie

    VISITOR_PRIVACY_METADATA

  • Duration

    6 months

  • Description

    YouTube sets this cookie to store the user's cookie consent state for the current domain.

  • Cookie

    __Secure-ROLLOUT_TOKEN

  • Duration

    6 months

  • Description

    YouTube sets this cookie to manage feature rollout and experimentation. It helps Google control which new features or interface changes are shown to users as part of testing and staged rollouts, ensuring consistent experience for a given user during an experiment.

  • Cookie

    __Secure-YNID

  • Duration

    6 months

  • Description

    YouTube cookie used to protect user security and prevent fraud, especially during the login process.

  • Cookie

    __Secure-YEC

  • Duration

    past

  • Description

    Description is currently not available.

Uncategorised

Other uncategorised cookies are those that are being analysed and have not been classified into a category as yet.

No cookies to display.

Reject All Save My Preferences Accept All

Powered by Cookieyes logo

Skip to content

Immucell - First Defense

Find a Retailer

Immucell - First Defense

Toggle Menu

BLOG

Practical ideas and answers to calf health and calf scours prevention.

Beef Calf

Roughly a Third of Beef Calves May Miss Colostrum Protection

By Rebekah Mathews, M.S.

Originally published in Drovers as Borrowing from Dairy: Why Beef Calves Need a Colostrum Strategy

Research suggests that between 5.8% and 34.5% of beef calves experience failure of passive transfer, meaning they don’t absorb enough antibodies from colostrum, even when they appear to be nursing normally. That finding comes from a 2025 review by Abdelfattah, Fausak and Maier that pooled results from more than 60 studies. It challenges a common belief in cow-calf operations that a calf seen suckling a willing dam is adequately protected.

In a recent Drovers article, Rebekah Mathews explains how dairy calf management can inform beef producers. Mathews studied ruminant production and economics before focusing on dairy gastrointestinal development in graduate school, and she is the Midwest region sales and marketing manager for First Defense. Dairies feed tested colostrum on a schedule and then use blood tests to confirm each calf’s antibody levels. Beef producers usually can’t do either and depend on watching calves after birth. Weak calves that are slow to stand or nurse face the highest risk. Poor colostrum quality, delayed or limited intake and crowded calving areas also play a role. Calves that miss out are more likely to die, to need treatment for scours or respiratory disease, and possibly to gain more slowly.

According to the review, timing matters more than whether colostrum comes from the dam or a replacer. Calves that take in enough colostrum within about four hours of birth are more likely to reach adequate antibody levels and less likely to need treatment later. Because constant observation isn’t practical on pasture, Mathews discusses how USDA-validated antibody products can help protect calves whose intake is uncertain.

Her central argument is that producers should treat every calf’s immunity as something that varies, not something guaranteed, and make the hours right after birth a priority each calving season. The full article also compares dairy and beef colostrum protocols side by side.

SEE THE FULL ARTICLE

Recent Posts

First Defense products are developed and manufactured by ImmuCell Corporation, an entrepreneurial animal health company that develops, manufactures and markets scientifically proven products that maximize the genetic potential of dairy and beef calves through disease prevention and reduced dependence on antibiotics.

Where to purchase First Defense Get our research and insights

Facebook YouTube Instagram

ImmuCell Corporation

56 Evergreen Drive
Portland, ME 04103
Phone: 800.466.8235

© 2026 Immucell Corporation | All Rights Reserved | Privacy Policy | Terms of Use | Resource Login | FFL

Find a Retailer

Prompts

ImmuCell Corporation (ticker ICCC), listed in United States.

ETFs Holding ImmuCell Corporation

ETF Weight in ETF Shares Market value As of
DXUV 0.00% 2,997 $ 30.629K Nov 12, 2026
DFAT 0.00% 7,528 $ 76.936K Nov 12, 2026
DFSU 0.00% 568 $ 5,804.96 Nov 12, 2026
DFAC 0.00% 18,492 $ 188.988K Nov 12, 2026
DCOR 0.00% 2,370 $ 24.221K Nov 12, 2026